KCT0008462
Completed
未知
Survival benefit of living donor liver transplantation in patients with high model for end-stage liver disease (MELD) score
Yonsei University Health System, Severance Hospital0 sites800 target enrollmentStarted: TBDLast updated:
Overview
- Phase
- 未知
- Status
- Completed
- Enrollment
- 800
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational Study
Eligibility Criteria
- Ages
- 18(Year) to o Limit (—)
- Sex
- All
Inclusion Criteria
- •Between September 2005 and December 2021, patients with a MELD score \>\=30 who were on the waiting list for LT at Severance Hospital were retrospectively reviewed.
Exclusion Criteria
- •hepatocellular carcinoma (HCC) with distant metastasis
- •any other malignancy diagnosed within 5 years
- •significant deterioration in health status within 2 days of placement on the waitlist
Investigators
Similar Trials
Completed
Not Applicable
Mortality, Morbidity and Risk Factors of Liver RetransplantationLiver Transplant; ComplicationsLiver Transplant RejectionLiver Transplant FailureLiver DiseasesLiver CirrhosisLiver FailureOrgan Transplant Failure or RejectionNCT04789213Memorial Bahçelievler Hospital32
Completed
Not Applicable
Long-term Follow-up of Living Liver Donors: A Single-center ExperienceLiver TransplantationNCT04814290Mansoura University476
Recruiting
Not Applicable
Benefit of ESP Peri Operative Analgesia for Live Liver Donor TransplantationLiver Transplant DisorderNCT04570969Vinmec Healthcare System24
Recruiting
Not Applicable
Evaluation of short term outcomes of liver transplantation from COVID-19 positive deceased donorsIRCT20200928048867N1Mashhad University of Medical Sciences10
Recruiting
Not Applicable
Liver Transplantation for Non-resectable Perihilar CholangiocarcinomaPerihilar CholangiocarcinomaKlatskin TumorBile Duct CancerNCT04993131Oslo University Hospital15